Leukemia Therapeutics MarketGlobal Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Global Leukemia Therapeutics Market is estimated to value over USD 18.6 billion by 2026 end and register a CAGR of over 5.8% during the forecast period 2019 to 2026.
The global leukemia therapeutics market growth is driven by the
increasing prevalence of persistent diseases globally. Leukemia is diagnosed by
the spread of chronic and acute disease that is frequently caused owing to the
radiation exposure, environmental factors and unhealthy lifestyle choices. The
high unmet needs pertaining to early diagnosis and treatment of leukemia and
rising aged population base are the important factors steering the market
growth. As per the report by the World Health Organization (WHO), leukemia is
the most prevalent blood cancer, especially in males, all across the world.
The Acute Myeloid Leukemia
Segment Dominated the Global Market
The Acute myeloid leukemia segment subjugated the therapeutics
market due to a rise in the number of incidences, high rates of drugs consumed
for treatments and quick absorption of second-gen tyrosine inhibitors. The
leukemia diagnosis segment is researched pertaining to MRI, biopsy and CT scan.
For chemotherapy treatments and chronic lymphatic leukemia radiation therapy
were the most widely used techniques in 2015. The CVAD treatment subjugated the
global market of chemotherapy treatments in 2014. The bone marrow transplant
and stem cell therapy are the emerging global leukemia therapeutics market
trends and are projected to stimulate the proliferation of the market. The
Drugs used for leukemia treatment are Omapro, Vidaza, Gleevec, GA101,
Vasaroxine, Tosedosat, Marqibo, Sapacitabine, Bosutinib, Dacogen, Graspa, and
Revlimid. Gleevec was one of the main contributors to the market growth in
2013.
The North America region held the largest global leukemia
therapeutics market in 2016 owing to the ever-increasing awareness amongst
patients, advancements in technology, government policies that bolster the rise
in investments and incentives, the systematic infrastructure of healthcare
systems are the important factors contributing to its dominance. The European
region is the second-largest market owing to the introduction of new brands
such as Arragon, Tasigna, Clolar and Sprycel and a wider product presence
without any expiration of the patent.
Key market players included in the global leukemia therapeutics
industry are Novartis AG, AbbVie, Bristol-Myers Squibb, F. Hoffmann-La Roche,
Sanofi, Pfizer, Amgen, Gilead Sciences, Takeda, Celgene.
Novartis is currently leading the global leukemia therapeutics
market, due to its innovative therapies and strong sales channel. The company
infused over 17% of its total revenue over the research and development sector.
Novartis, in May 2018, announced its CAR-T cell therapy for the second
indication patient treatment with refractory or relapsed large B-cell lymphoma.
With the announcement of Kymriah, Novartis is now a major market player of
immunotherapies for treating leukemia.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3453&page=requestsample
Global Leukemia Therapeutics Market Segmentation:
By Type of Leukemia
- Chronic Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
By Treatment Type
- Targeted Drugs &
Immunotherapy
- Chemotherapy
By Molecule Type
- Small Molecules
- Biologics
By Mode of Administration
- Oral Mode
- Injectable Mode
By Gender
- Males
- Females
By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Purchase a Copy & Ask For
Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3453&page=askfordiscount
FutureWise Key Takeaways:
- Growth prospects
- SWOT analysis
- Key trends
- Key data-points affecting market
growth
Objectives of the Study:
- To provide with an exhaustive
analysis on the global leukemia therapeutics market by type of leukemia,
by treatment type, by molecule type, by mode of administration, by gender
and by region
- To cater comprehensive information on
factors impacting market growth (drivers, restraints, opportunities, and
industry-specific restraints)
- To evaluate and forecast
micro-markets and the overall market
- To predict the market size, in key
regions (along with countries)— North America, Europe, Asia Pacific and
the rest of the world
- To record evaluate and competitive
landscape mapping- product launches, technological advancements, mergers
and expansions
- Profiling of companies to evaluate
their market shares, strategies, financials and core competencies
About
FutureWise Research:
We specialise in high-growth niche markets, assuring
flexibility, agility and customised solutions for our clients. Through in-depth
market insights and consultancy, we present our clients with the tools they
need to be at the forefront of their industry – a position secured for far more
than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Comments
Post a Comment